Premium
FluoroPharma Medical Inc (CE) (FPMI)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
MORGANTOWN, W. Va., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. ("Protea"), a leader in the field of bioanalytics, announced today that Thijs Spoor and Josiah T. Austin have...
MONTCLAIR, N.J., Aug. 22, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
MONTCLAIR, N.J., July 26, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
MONTCLAIR, N.J., June 18, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough molecular imaging products that utilize...
MONTCLAIR, N.J., June 15, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron...
BOSTON, May 31, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron...
BOSTON, March 19, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI) today announces that BFPET, its imaging agent for measuring cardiovascular blood flow, has been granted patent...
BOSTON, March 1, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of breakthrough diagnostic imaging products that utilize positron...
BOSTON, Jan. 13, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products, today...
BOSTON, Dec. 30, 2011 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI) is pleased to announce that Lawrence Atinsky has been appointed to the Board of Directors of FluoroPharma effective...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 40000 | 0.0001 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 22500 | 0.0001 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 80833 | 0.0001 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 41083 | 0.0001 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0002 | 0.0001 | 30185 | 0.00010011 | CS |
| 156 | 9.9E-5 | 9900 | 1.0E-6 | 0.0052 | 1.0E-6 | 57001 | 0.00160902 | CS |
| 260 | -0.002 | -95.2380952381 | 0.0021 | 0.079 | 1.0E-6 | 125539 | 0.0144086 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
